Two oral COVID-19 treatments get provisional approval from TGA

Australia’s Therapeutic Goods Administration (TGA) has today granted provisional approval to two oral COVID-19 treatments for use in adults at increased risk of progression to hospitalisation or death.

Both PAXLOVID (manufactured by Pfizer Australia) and LAGEVRIO (manufactured by the Australian…